HAEMONETICS CORP
HAEMONETICS CORP
Aktie · US4050241003 · HAE · 881782 (XNYS)
Übersicht Finanzkennzahlen
Kein Kurs
10.09.2025 21:40
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Analyst Grade Summary
gauge-img
Kaufen
Starker Kauf
Kaufen
Halten
Verkaufen
Starker Verkauf
0
10
8
0
0
Aktuelle Kurse von HAEMONETICS CORP
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNYS: NYSE
NYSE
HAE
USD
10.09.2025 21:40
53,67 USD
-0,57 USD
-1,05 %
ESG-Risiko-Rating
B Gering
Free Float & Liquidität
Free Float 98,61 EUR
Shares Float 47,51 M EUR
Ausstehende Aktien 48,18 M EUR
Firmenprofil zu HAEMONETICS CORP Aktie
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Unternehmensdaten

Name HAEMONETICS CORP
Firma Haemonetics Corporation
Symbol HAE
Website https://www.haemonetics.com
Heimatbörse XNYS NYSE
WKN 881782
ISIN US4050241003
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Christopher A. Simon
Marktkapitalisierung 3 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 3,7 T
Adresse 125 Summer Street, 02110 Boston
IPO Datum 1991-05-10

Aktien-Splits

Datum Split
03.12.2012 2:1
11.01.1993 2:1

Ticker Symbole

Name Symbol
Frankfurt HAZ.F
NYSE HAE
Weitere Aktien
Investoren, die HAEMONETICS CORP halten, haben auch folgende Aktien im Depot:
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
AUTOMATIC DATA PROCESSING INC
AUTOMATIC DATA PROCESSING INC Aktie
Chavant Capital Acquisition Corp.
Chavant Capital Acquisition Corp. Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
GOLDEN NUGGET ONLINE GAMING INC - CLASS A
GOLDEN NUGGET ONLINE GAMING INC - CLASS A Aktie
Goldiam International Limited
Goldiam International Limited Aktie
HONEYWELL INTERNATIONAL INC
HONEYWELL INTERNATIONAL INC Aktie
INTEL CORP
INTEL CORP Aktie
MICROSOFT CORP
MICROSOFT CORP Aktie
QIAGEN NV (alt)
QIAGEN NV (alt) Aktie
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Aktie
WRAPPED BITCOIN
WRAPPED BITCOIN Crypto
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025